Time to talk.
View the pdf of this story
The use of genetic testing to diagnose and predict the future development and progress of disease is a highly controversial topic in the UK life and health insurance
More on Regulation
In memory
With great sadness we confirm that Sir David Rowland, our former Chairman from 1993 to 1997, has passed away. He played a critical role in safeguarding the future of the Lloyd’s market through perhaps its most difficult period.
— Lloyd's (@LloydsofLondon) February 18, 2019
More: https://t.co/2cS2H7c8Tk pic.twitter.com/jzL5UnIx4x
Most read
- Court throws out claim that would have created 'fraudsters' charter'
- Axa UK shifts focus to commercial as it makes profit
- Markerstudy Gibraltar business cost Qatar Re owner £37.9m
- My other life: James Neale, DWF, Britain's Got Talent finalist
- Drivers in autonomous vehicles 'shouldn't be held liable'
- Ageas UK CEO Andy Watson issues caution on Brexit claims inflation impact
- Ageas UK says long goodbye to Ogden impact as CEO Watson hails ‘strong’ motor performance
Back to Top